Berkshire Biomedical, Developers of COPA™, Recognizes National Prescription Drug Take Back Day

DALLAS, April 29, 2022 /PRNewswire/ — Berkshire Biomedical Corporation (“Berkshire” or “the Company”), focused on developing its proprietary, hand-held, automated personalized drug dispensing technology to enhance patient wellness, today announced its support and recognition of the DEA’s…

About the Author

has written 39584 stories on this site.

Copyright © 2010 Business and Corporate News.